Scilex Holding Company Stock Issued During Period, Value, Purchase of Assets
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Scilex Holding Company stock issued during period, value, purchase of assets for the quarter ending 2022-12-31 was $5.73M.
- Scilex Holding Company stock issued during period, value, purchase of assets for fiscal 2022 was $8.71M.
| Period end | Stock Issued During Period, Value, Purchase of Assets 3 month | Stock Issued During Period, Value, Purchase of Assets 12 month |
|---|---|---|
| 2022-12-31 | $5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $8.71M 10-K · filed 2024-03-12 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |